BCG treatment in Tis of the urinary bladder, results of the EORTC Protocol 30861. EORTC GU Group.
Jakse
G
G
Department of Urology, RWTH Aachen, Germany.
Hall
R
R
Bono
A
A
Höltl
W
W
Carpentier
P
P
de Pauw
M
M
Sylvester
R
R
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001500:BCG Vaccine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002278:Carcinoma in Situ / Q000628:therapy*; D002295:Carcinoma, Transitional Cell / Q000628:therapy; D002985:Clinical Protocols; D003556:Cystitis / Q000209:etiology; D006801:Humans; D008875:Middle Aged; D011446:Prospective Studies; D014374:Tuberculin Test; D001749:Urinary Bladder Neoplasms / Q000628:therapy*
D001500:BCG Vaccine